Get the Stockscreener App
2.41
0.00%
0.00
After Hours:
2.41
Lisata Therapeutics Inc Stock (LSTA) Forecast
The Lisata Therapeutics Inc (LSTA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2.7051, representing a +12.25% increase from the current price of $2.41. The highest analyst price target is $2.8951, and the lowest is $2.5151.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month LSTA Price Target
Average 2.3677
(-1.75% Downside)
Is Lisata Therapeutics Inc (LSTA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 56.40 | Neutral |
| STOCH(9,6) | 66.36 | Neutral |
| STOCHRSI(14) | 58.16 | Neutral |
| MACD(12,26) | 0.0544 | Buy |
| ADX(14) | 16.45 | Neutral |
| William %R | -25.45 | Neutral |
| CCI(14) | 27.59 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.4243
Sell
|
2.383
Buy
|
| MA20 |
2.2367
Buy
|
2.3247
Buy
|
| MA50 |
2.2776
Buy
|
2.3555
Buy
|
| MA100 |
2.6007
Sell
|
2.5072
Sell
|
| MA200 |
2.7896
Sell
|
2.6862
Sell
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, LSTA could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 5 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on LSTA, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 56.4 indicates that LSTA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 66.36 indicates that LSTA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 58.16 indicates that LSTA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 16.45 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 27.59 indicates that LSTA is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term LSTA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Lisata Therapeutics Inc financial reports and earnings history, Lisata Therapeutics Inc (LSTA) stock could reach $1.1126 by 2030, $2.6128 by 2040 and $5.1789 by 2050. See the projected annual prices until 2050 of the Lisata Therapeutics Inc stock below:
- Lisata Therapeutics Inc (LSTA) is expected to reach an average price of $0.2777 in 2035, with a high prediction of $0.5385 and a low estimate of $0.0389. This indicates an $-88.48% rise from the last recorded price of $2.41.
- Lisata Therapeutics Inc (LSTA) stock is projected to chart a bullish course in 2040, with an average price target of $2.7702, representing an $14.95% surge from its current level. The forecast ranges from a conservative $2.8702 to a sky-high $2.6128.
- Our analysts predict Lisata Therapeutics Inc (LSTA) to jump 36.26% by 2045, soaring from $3.324 to an average price of $3.284, potentially reaching $3.2085. While $3.324 is the low estimate, the potential upside is significant.
- Lisata Therapeutics Inc (LSTA) stock is expected to climb by 2050, reaching an average of $5.3689, a $122.78% jump from its current level. However, a wide range of estimates exists, with high and low targets of $5.1789 and $5.396, respectively, highlighting the market's uncertainty.
Lisata Therapeutics Inc Stock (LSTA) Year by Year Forecast
Lisata Therapeutics Inc Stock (LSTA) Price Forecast for 2025
Lisata Therapeutics Inc Stock (LSTA) is expected to reach an average price of $2.6105 in 2025, with a high prediction of $3.6453 and a low estimate of $1.5756. This indicates an +8.32% rise from the last recorded price of $2.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2025 | $2.6779 | $2.5151 | $2.8951 | +11.12% |
| July, 2025 | $2.3025 | $2.2725 | $2.9988 | -4.46% |
| August, 2025 | $2.3964 | $2.1245 | $2.5764 | -0.56% |
| September, 2025 | $2.2138 | $2.0883 | $2.462 | -8.14% |
| October, 2025 | $3.2031 | $2.0957 | $3.3831 | +32.91% |
| November, 2025 | $3.3305 | $2.5849 | $3.5905 | +38.20% |
| December, 2025 | $2.8298 | $2.5279 | $3.6453 | +17.42% |
Lisata Therapeutics Inc Stock (LSTA) Price Forecast for 2026
The predicted value for Lisata Therapeutics Inc (LSTA) in 2026 is set at an average of $2.0408. Estimates vary from a peak of $2.9915 to a trough of $1.0902, indicating an -15.32% surge from the present price of $2.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.3373 | $2.1789 | $2.9915 | -3.02% |
| February, 2026 | $1.3146 | $1.2046 | $2.419 | -45.45% |
| March, 2026 | $1.212 | $1.0902 | $1.578 | -49.71% |
| April, 2026 | $1.1713 | $1.1513 | $1.5494 | -51.40% |
| May, 2026 | $1.4687 | $1.1731 | $1.595 | -39.06% |
| June, 2026 | $1.7761 | $1.2124 | $1.9661 | -26.30% |
| July, 2026 | $2.1954 | $1.7448 | $2.3754 | -8.90% |
| August, 2026 | $1.8328 | $1.601 | $2.2473 | -23.95% |
| September, 2026 | $2.2921 | $1.7448 | $2.4902 | -4.89% |
| October, 2026 | $2.3195 | $2.124 | $2.5976 | -3.76% |
| November, 2026 | $1.8547 | $1.7584 | $2.4014 | -23.04% |
| December, 2026 | $1.8802 | $1.6324 | $2.1196 | -21.98% |
Lisata Therapeutics Inc Stock (LSTA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Lisata Therapeutics Inc (LSTA) is $1.9308, with a high forecast of $3.2014 and a low forecast of $0.6603. This indicates an -19.88% decrease from the last price of $2.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.8963 | $1.6435 | $2.1235 | -21.32% |
| February, 2027 | $2.5368 | $1.7591 | $2.9346 | +5.26% |
| March, 2027 | $2.5364 | $2.4952 | $3.2014 | +5.25% |
| April, 2027 | $2.1424 | $2.0869 | $2.5741 | -11.10% |
| May, 2027 | $1.4236 | $1.3936 | $2.3108 | -40.93% |
| June, 2027 | $0.8475 | $0.7675 | $1.5863 | -64.84% |
| July, 2027 | $0.8898 | $0.6603 | $1.0327 | -63.08% |
| August, 2027 | $0.8997 | $0.7269 | $1.1242 | -62.67% |
| September, 2027 | $0.9336 | $0.7936 | $1.2436 | -61.26% |
| October, 2027 | $1.5848 | $0.8464 | $1.842 | -34.24% |
| November, 2027 | $1.7159 | $1.4153 | $1.9631 | -28.80% |
| December, 2027 | $1.8998 | $1.1914 | $1.8998 | -21.17% |
Lisata Therapeutics Inc Stock (LSTA) Price Forecast for 2028
In 2028, Lisata Therapeutics Inc (LSTA) is projected to reach an average price of $1.494, with a high projection of $2.7576 and a low estimate of $0.2303. This indicates an -38.01% fall from the last price of $2.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.9609 | $1.5826 | $2.0853 | -18.63% |
| February, 2028 | $1.872 | $1.642 | $2.1965 | -22.32% |
| March, 2028 | $1.664 | $1.3333 | $1.9948 | -30.95% |
| April, 2028 | $1.2639 | $1.1765 | $1.6628 | -47.55% |
| May, 2028 | $1.5025 | $1.1913 | $1.6713 | -37.66% |
| June, 2028 | $2.4317 | $1.4163 | $2.4923 | +0.90% |
| July, 2028 | $1.9321 | $1.7876 | $2.7576 | -19.83% |
| August, 2028 | $1.4207 | $1.347 | $2.1132 | -41.05% |
| September, 2028 | $0.8755 | $0.8618 | $1.8744 | -63.67% |
| October, 2028 | $0.4603 | $0.2303 | $0.8842 | -80.90% |
| November, 2028 | $0.4389 | $0.244 | $0.6989 | -81.79% |
| December, 2028 | $0.4837 | $0.3026 | $0.75 | -79.93% |
Lisata Therapeutics Inc Stock (LSTA) Price Forecast for 2029
The 2029 price forecast for Lisata Therapeutics Inc Stock (LSTA) is $1.3443 on average, with a high prediction of $2.3138 and a low estimate of $0.3748. This represents an -44.22% decrease from the previous price of $2.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.9423 | $0.3748 | $1.1323 | -60.90% |
| February, 2029 | $1.2944 | $0.9128 | $1.4471 | -46.29% |
| March, 2029 | $0.8319 | $0.7819 | $1.5508 | -65.48% |
| April, 2029 | $1.3668 | $0.8656 | $1.493 | -43.29% |
| May, 2029 | $1.5953 | $1.3005 | $1.7953 | -33.81% |
| June, 2029 | $1.1101 | $1.0801 | $1.779 | -53.94% |
| July, 2029 | $1.026 | $0.7855 | $1.3175 | -57.43% |
| August, 2029 | $1.0142 | $0.7206 | $1.2192 | -57.92% |
| September, 2029 | $1.8577 | $0.8438 | $2.0377 | -22.92% |
| October, 2029 | $1.7809 | $1.2424 | $2.3138 | -26.10% |
| November, 2029 | $1.5094 | $1.2048 | $2.0254 | -37.37% |
| December, 2029 | $1.0281 | $0.8697 | $1.674 | -57.34% |
Lisata Therapeutics Inc Stock (LSTA) Price Forecast for 2030
Lisata Therapeutics Inc Stock (LSTA) is expected to reach an average price of $0.6976 in 2030, with a high forecast of $1.3941 and a low forecast of $0.00116. This signifies an -71.05% decrease from the last price of $2.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.0212 | $0.00116 | $1.1126 | -99.12% |
| February, 2030 | $0.000303 | $0.0942 | $0.2855 | -99.99% |
| March, 2030 | $0.1018 | $0.0828 | $0.2736 | -95.78% |
| April, 2030 | $0.2068 | $0.00214 | $0.3275 | -91.42% |
| May, 2030 | $0.66 | $0.00858 | $1.01 | -72.62% |
| June, 2030 | $0.9585 | $0.5246 | $1.1385 | -60.23% |
| July, 2030 | $0.6217 | $0.3724 | $1.0131 | -74.20% |
| August, 2030 | $1.0802 | $0.5763 | $1.2756 | -55.18% |
| September, 2030 | $1.1188 | $0.915 | $1.3941 | -53.58% |
| October, 2030 | $0.7519 | $0.542 | $1.2034 | -68.80% |
| November, 2030 | $0.5153 | $0.2648 | $0.8866 | -78.62% |
| December, 2030 | $0.5426 | $0.287 | $0.767 | -77.49% |
0.39%
3.66%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):